hematoxylin has been researched along with glycosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Li, L; Li, Y; Liu, X; Liu, Y; Zhang, D | 1 |
| Li, Q; Liu, X; Zhang, H | 1 |
2 other study(ies) available for hematoxylin and glycosides
| Article | Year |
|---|---|
23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Caspases; Cyclooxygenase 2; Eosine Yellowish-(YS); Glycosides; Hematoxylin; I-kappa B Proteins; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Edema; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Triterpenes; Tumor Necrosis Factor-alpha | 2023 |
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cytokines; Eosine Yellowish-(YS); Flavonoids; Glucose; Glycosides; Hematoxylin; Inflammation; Interleukin-6; Monocyte Chemoattractant Proteins; Oxygen; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Reperfusion Injury; Signal Transduction; Tumor Necrosis Factors | 2022 |